N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans

Volumn 100 E, Issue , 2012, Pages 323-335

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; DRINKING WATER; NITROSAMINE; NITROSONORNICOTINE;

ARTICLE; CANCER RISK; CARCINOGENICITY; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CIGARETTE SMOKING; DISEASE ASSOCIATION; ESOPHAGUS CANCER; EXPOSURE; HEALTH HAZARD; HUMAN; LIVER CANCER; LIVER TUMOR; LUNG CANCER; LUNG TUMOR; MOLECULAR EPIDEMIOLOGY; MOLECULAR WEIGHT; MOUTH CANCER; NONHUMAN; NOSE CANCER; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SMOKELESS TOBACCO; STOMACH CANCER; SYNTHESIS; TOBACCO; TRACHEA TUMOR;

EID: 84856800866     PISSN: 10171606     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (46)

1. Amin S, Desai D, Hecht SS, Hoffmann D (1996). Synthesis of tobacco-specific N-nitrosamines and their metabolites and results of related bioassays. Crit Rev Toxicol, 26: 139-147. doi:10.3109/10408449609017927PMID:8688157
2. Anderson LM, Hecht SS, Kovatch RM et al. (1991). Tumorigenicity of the tobacco-specific carcinogen 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone in infant mice. Cancer Lett, 58: 177-181. doi:10.1016/0304-3835(91)90097-2 PMID:1855194
3. Beebe LE, Kim YE, Amin S et al. (1993). Comparison of transplacental and neonatal initiation of mouse lung and liver tumors by N-nitrosodimethylamine (NDMA) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and promotability by a polychlorinated biphenyls mixture (Aroclor 1254). Carcinogenesis, 14: 1545-1548. doi:10.1093/carcin/14.8.1545 PMID:8353839
4. Belinsky SA, Devereux TR, Foley JF et al. (1992). Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res, 52: 3164-3173. PMID:1591728
5. Belinsky SA, Foley JF, White CM et al. (1990). Doseresponse relationship between O6- methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone. Cancer Res, 50: 3772-3780.PMID:2340522
6. Castonguay A, Lin D, Stoner GD et al. (1983). Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N'-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and their analogues. Cancer Res, 43: 1223-1229. PMID:6825093
7. Castonguay A, Rivenson A, Trushin N et al. (1984). Effects of chronic ethanol consumption on the metabolism and carcinogenicity of N'-nitrosonornicotine in F344 rats. Cancer Res, 44: 2285-2290. PMID:6722769
8. Church TR, Anderson KE, Caporaso NE et al. (2009). A prospectively measured serum biomarker for a tobaccospecific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev, 18: 260-266.doi:10.1158/1055-9965.EPI-08-0718 PMID:19124507
9. Correa E, Joshi PA, Castonguay A, Schüller HM (1990). The tobacco-specific nitrosamine 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone is an active transplacental carcinogen in Syrian golden hamsters. Cancer Res, 50: 3435-3438. PMID:2334940
10. Deutsch-Wenzel RP, Brune H, Grimmer G, Misfeld J (1985). Local application to mouse skin as a carcinogen specific test system for non-volatile nitroso compounds. Cancer Lett, 29: 85-92. doi:10.1016/0304-3835(85)90127-2 PMID:3933815
11. Ding YS, Zhang L, Jain RB et al. (2008). Levels of tobacco-specific nitrosamines and polycyclic aromatic hydrocarbons in mainstream smoke from different tobacco varieties. Cancer Epidemiol Biomarkers Prev, 17: 3366-3371. doi:10.1158/1055-9965.EPI-08-0320PMID:19064552
12. Hammond D & O'Connor RJ (2008). Constituents in tobacco and smoke emissions from Canadian cigarettes. Tob Control, 17: Suppl 1i24-i31. doi:10.1136/tc.2008.024778 PMID:18768456
13. Hecht SS, Abbaspour A, Hoffman D (1988). A study of tobacco carcinogenesis. XLII. Bioassay in A/J mice of some structural analogues of tobacco-specific nitrosamines. Cancer Lett, 42: 141-145. doi:10.1016/0304- 3835(88)90251-0 PMID:3180033
14. Hecht SS, Chen CB, Hirota N et al. (1978). Tobacco-specific nitrosamines: formation from nicotine in vitro and during tobacco curing and carcinogenicity in strain A mice. J Natl Cancer Inst, 60: 819-824. PMID:633391
15. Hecht SS, Morse MA, Amin S et al. (1989). Rapid singledose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet. Carcinogenesis, 10: 1901-1904.doi:10.1093/carcin/10.10.1901 PMID:2791206
16. Hecht SS, Rivenson A, Braley J et al. (1986b). Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res, 46: 4162-4166.PMID:3731083
17. Hecht SS, Trushin N, Castonguay A, Rivenson A (1986a). Comparative tumorigenicity and DNA methylation in F344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone and N-nitrosodimethylamine. Cancer Res, 46: 498-502. PMID:3940627
18. Hecht SS, Young R, Maeura Y (1983). Comparative carcinogenicity in F344 rats and Syrian golden hamsters of N'-nitrosonornicotine and N'-nitrosonornicotine-1-N-oxide. Cancer Lett, 20: 333-340. doi:10.1016/0304-3835(83)90032-0 PMID:6627230
19. Hilfrich J, Hecht SS, Hoffmann D (1977). A study of tobacco carcinogenesis. XV. Effects of N'-nitrosonornicotine and N'-nitrosoanabasine in Syrian golden hamsters. Cancer Lett, 2: 169-175. doi:10.1016/S0304-3835(77)80007-4 PMID:837363
20. Hoffmann D, Castonguay A, Rivenson A, Hecht SS (1981). Comparative carcinogenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine in Syrian golden hamsters. Cancer Res, 41: 2386-2393. PMID:7237437
21. Hoffmann D, Hecht SS, Ornaf RM, Wynder EL (1974). N'-nitrosonornicotine in tobacco. Science, 186: 265-267. doi:10.1126/science.186.4160.265 PMID:4414773
22. Hoffmann D, Raineri R, Hecht SS et al. (1975). A study of tobacco carcinogenesis. XIV. Effects of N'-nitrosonornicotine and N'-nitrosonanabasine in rats. J Natl Cancer Inst, 55: 977-981. PMID:1237631
23. Hoffmann D, Rivenson A, Abbi R, Wynder EL (1993). A study of tobacco carcinogenesis: effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res, 53: 2758-2761. PMID:8389244
24. Hoffmann D, Rivenson A, Amin S, Hecht SS (1984). Doseresponse study of the carcinogenicity of tobacco-specific N-nitrosamines in F344 rats. J Cancer Res Clin Oncol, 108: 81-86. doi:10.1007/BF00390978 PMID:6746721
25. IARC (1985). Tobacco habits other than smoking; betelquid and areca-nut chewing; and some related nitrosamines. IARC Monogr Eval Carcinog Risk Chem Hum, 37: 1-268. PMID:3866741
26. IARC (1986). Tobacco smoking. IARC Monogr Eval Carcinog Risk Chem Hum, 38: 1-421. PMID:3866741
27. IARC (2004). Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum, 83: 1-1438.PMID:15285078
28. IARC (2007). Smokeless tobacco and some tobaccospecific N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum, 89: 1-592. PMID:18335640
29. Kim Y, Liu XS, Liu C et al. (2006). Induction of pulmonary neoplasia in the smoke-exposed ferret by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): a model for human lung cancer. Cancer Lett, 234: 209-219. doi:10.1016/j.canlet.2005.03.052PMID:15894421
30. Koppang N, Rivenson A, Dahle HK, Hoffmann D (1997). A study of tobacco carcinogenesis, LIII: carcinogenicity of N'-nitrosonornicotine (NNN) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in mink (Mustela vison). Cancer Lett, 111: 167-171. doi:10.1016/S0304-3835(96)04507-7PMID:9022142
31. Koppang N, Rivenson A, Reith A et al. (1992). A study of tobacco carcinogenesis XLVIII. Carcinogenicity of N'-nitrosonornicotine in mink (Mustela vison). Carcinogenesis, 13: 1957-1960. doi:10.1093/carcin/13.11.1957 PMID:1423862
32. LaVoie EJ, Prokopczyk G, Rigotty J et al. (1987). Tumorigenic activity of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), 4-(methylnitrosamino)-4-(3-pyridyl)-1- butanol (iso-NNAL) and N'-nitrosonornicotine (NNN) on topical application to Sencar mice. Cancer Lett, 37: 277-283. doi:10.1016/0304-3835(87)90112-1PMID:3677059
33. McCoy GD, Hecht SS, Katayama S, Wynder EL (1981). Differential effect of chronic ethanol consumption on the carcinogenicity of N-nitrosopyrrolidine and N'-nitrosonornicotine in male Syrian golden hamsters. Cancer Res, 41: 2849-2854. PMID:7248945
34. Padma PR, Lalitha VS, Amonkar AJ, Bhide SV (1989). Carcinogenicity studies on the two tobaccospecific N-nitrosamines, N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis, 10: 1997-2002. doi:10.1093/carcin/10.11.1997 PMID:2680142
35. Prokopczyk B, Rivenson A, Hoffmann D (1991). A study of betel quid carcinogenesis. IX. Comparative carcinogenicityof 3-(methylnitrosamino)propionitrile and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone upon local application to mouse skin and rat oral mucosa. Cancer Lett, 60: 153-157. doi:10.1016/0304-3835(91)90222-4 PMID:1933838
36. Richter P, Hodge K, Stanfill S et al. (2008). Surveillance of moist snuff: total nicotine, moisture, pH, un-ionizednicotine, and tobacco-specific nitrosamines. Nicotine Tob Res, 10: 1645-1652. doi:10.1080/14622200802412937 PMID:18988077
37. Rickert WS, Joza PJ, Sharifi M et al. (2008). Reductions in the tobacco specific nitrosamine (TSNA) content of tobaccos taken from commercial Canadian cigarettes and corresponding reductions in TSNA deliveriesin mainstream smoke from such cigarettes. Regul Toxicol Pharmacol, 51: 306-310. doi:10.1016/j.yrtph.2008.04.009 PMID:18508168
38. Rivenson A, Djordjevic MV, Amin S, Hoffmann R (1989). A study of tobacco carcinogenesis XLIV. Bioassay in A/J mice of some N-nitrosamines. Cancer Lett, 47: 111-114.doi:10.1016/0304-3835(89)90185-7 PMID:2636026
39. Rivenson A, Hoffmann D, Prokopczyk B et al. (1988). Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res, 48: 6912-6917.PMID:3180100
40. Schüller HM, Jorquera R, Lu X et al. (1994). Transplacental carcinogenicity of low doses of 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone administered subcutaneously or intratracheally to hamsters. J Cancer Res Clin Oncol, 120: 200-203. doi:10.1007/BF01372556 PMID:8288673
41. Schüller HM, Witschi HP, Nylen E et al. (1990). Pathobiology of lung tumors induced in hamsters by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the modulating effect of hyperoxia. Cancer Res, 50: 1960-1965. PMID:2306745
42. Schüller HM, Zhang L, Weddle DL et al. (2002). The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to thanol and the tobacco carcinogen NNK. J Cancer Res Clin Oncol, 128: 525-532. doi:10.1007/s00432-002-0365-y PMID:12384795
43. Stepanov I, Carmella SG, Briggs A et al. (2009a). Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products. Cancer Res, 69: 8236-8240. doi:10.1158/0008-5472.CAN-09-1084 PMID:19843845
44. Stepanov I, Carmella SG, Han S et al. (2009b). Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users. Nicotine Tob Res,11: 99-105. doi:10.1093/ntr/ntn004 PMID:19246447
45. Stepanov I, Jensen J, Hatsukami D, Hecht SS (2008a). New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res, 10: 1773-1782. doi:10.1080/14622200802443544PMID:19023828
46. Yuan JM, Koh WP, Murphy SE et al. (2009). Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res, 69: 2990-2995. doi:10.1158/0008-5472.CAN-08-4330 PMID:19318550